---
document_datetime: 2025-10-23 09:26:37
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rolcya-epar-all-authorised-presentations_en.pdf
document_name: rolcya-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0650578
conversion_datetime: 2025-12-26 11:10:11.945378
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging          | Content (concentration)   | Pack size              |
|------------------|-------------------|------------|------------------------|---------------------------|------------------------------|---------------------------|------------------------|
| EU/1/25/1958/001 | Rolcya            | 60 mg      | Solution for injection | Subcutaneous use          | pre - filled syringe (glass) | 1 ml (60mg/ml)            | 1 pre - filled syringe |